NCT04681235

Brief Summary

In our study, we tested the hypothesis of the safe effect applicability of motor training in the immersion high-tech polymodal VR system not only on the parameters of balance, gait, and motor status of the patient, but also on his cognitive functions and mental health in patients with a degree of disability no more than 3 points on a scale Rankin.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Oct 2019

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 27, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 27, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 18, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 23, 2020

Completed
Last Updated

December 23, 2020

Status Verified

December 1, 2020

Enrollment Period

10 months

First QC Date

December 18, 2020

Last Update Submit

December 22, 2020

Conditions

Keywords

StrokeVirtual realityRehabilitationMotion capture

Outcome Measures

Primary Outcomes (4)

  • Postural stability test (Grail Motekforce)

    The subject's ability to remain balanced under four different conditions is evaluated (cm/s).

    Change from baseline at 2 weeks

  • Six-minute walk test (6MWT) (Grail Motekforce)

    The 6-minute walk test evaluates how much distance a subject can cover in six minutes (m).

    Change from baseline at 2 weeks

  • Beck Depression Inventory

    Measures the severity of depression (0-63; 30-63 scores indicate severe depression)

    Change from baseline at 2 weeks

  • State-Trait Anxiety Inventory

    Examines two types of anxiety - state anxiety (anxiety about an event) and trait anxiety (anxiety level as a personal characteristic) with the score range from 20 to 80, where higher scores correspond to greater anxiety

    Change from baseline at 2 weeks

Secondary Outcomes (6)

  • Standing Balance Test

    Change from baseline at 2 weeks

  • Berg Balance Scale

    Change from baseline at 2 weeks

  • Timed Up and Go Test

    Change from baseline at 2 weeks

  • Hauser Ambulation Index

    Change from baseline at 2 weeks

  • Rivermead Activities of Daily Living Scales

    Change from baseline at 2 weeks

  • +1 more secondary outcomes

Study Arms (1)

Training Group

EXPERIMENTAL

Training Group recieved 10 sessions on VR (Grail Motekforce, Netherlands) during two weeks. One session lasted 40 minuties.

Other: Training on VR

Interventions

The training is aimed at improving the functioning of the motor sphere, including balance, gait, and upper limb function, as well as increasing the level of motivation and reducing the level of anxiety and depression. Game applications were selected based on therapeutic tasks of motor recovery.

Training Group

Eligibility Criteria

Age30 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • with a stroke, transferred at least 2 weeks ago; with no history of neurological or psychiatric disorders; able to maintain an upright posture and walk without support or with minimal support for at least 30 minutes; with stable hemodynamics;

You may not qualify if:

  • not having epileptic activity; not having serious ophthalmic disorders; less than 24 scores in MoCA

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health

Moscow, 117997, Russia

Location

MeSH Terms

Conditions

StrokeMotor DisordersAffective SymptomsGait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesMental DisordersBehavioral SymptomsBehaviorNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Marina A Shurupova

    Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health

    PRINCIPAL INVESTIGATOR
  • Alina D Aizenshtein

    Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health

    PRINCIPAL INVESTIGATOR
  • Galina Ivanova, Prof.

    Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health

    STUDY CHAIR
  • Nadezhda L Cherepahina, PhD

    Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 18, 2020

First Posted

December 23, 2020

Study Start

October 1, 2019

Primary Completion

July 27, 2020

Study Completion

July 27, 2020

Last Updated

December 23, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations